End-of-day quote
BURSA MALAYSIA
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2.67
MYR
|
0.00%
|
|
+1.52%
|
-1.11%
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
15,488
|
23,279
|
30,669
|
16,575
|
6,493
|
9,113
|
-
|
-
|
Enterprise Value (EV)
1 |
15,682
|
23,248
|
28,343
|
14,435
|
4,918
|
7,472
|
7,454
|
7,411
|
P/E ratio
|
34.2
x
|
53.6
x
|
10.6
x
|
5.12
x
|
-29.8
x
|
149
x
|
45.3
x
|
27.3
x
|
Yield
|
1.86%
|
1.08%
|
1.98%
|
11.8%
|
-
|
0.27%
|
1.17%
|
1.94%
|
Capitalization / Revenue
|
5.48
x
|
7.96
x
|
4.58
x
|
2.1
x
|
2.7
x
|
4.63
x
|
3.61
x
|
3.06
x
|
EV / Revenue
|
5.55
x
|
7.95
x
|
4.23
x
|
1.83
x
|
2.04
x
|
3.79
x
|
2.95
x
|
2.49
x
|
EV / EBITDA
|
23.2
x
|
32.3
x
|
7.19
x
|
3.06
x
|
14.3
x
|
42.4
x
|
19.8
x
|
13.6
x
|
EV / FCF
|
26
x
|
57
x
|
10.4
x
|
5.02
x
|
-14.3
x
|
46
x
|
34.1
x
|
25.3
x
|
FCF Yield
|
3.84%
|
1.75%
|
9.62%
|
19.9%
|
-7.02%
|
2.18%
|
2.93%
|
3.95%
|
Price to Book
|
6.79
x
|
9.11
x
|
6.16
x
|
3.23
x
|
1.4
x
|
1.94
x
|
1.91
x
|
1.86
x
|
Nbr of stocks (in thousands)
|
3,345,187
|
3,383,613
|
3,434,324
|
3,417,462
|
3,417,462
|
3,413,262
|
-
|
-
|
Reference price
2 |
4.630
|
6.880
|
8.930
|
4.850
|
1.900
|
2.670
|
2.670
|
2.670
|
Announcement Date
|
5/7/19
|
5/18/20
|
5/4/21
|
5/10/22
|
5/9/23
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,828
|
2,924
|
6,696
|
7,888
|
2,408
|
1,970
|
2,524
|
2,981
|
EBITDA
1 |
675.6
|
720.5
|
3,942
|
4,722
|
344
|
176.3
|
376.6
|
546.6
|
EBIT
1 |
572
|
595.4
|
3,804
|
4,570
|
180.8
|
13.96
|
199
|
350.8
|
Operating Margin
|
20.23%
|
20.36%
|
56.82%
|
57.94%
|
7.51%
|
0.71%
|
7.89%
|
11.77%
|
Earnings before Tax (EBT)
1 |
551.9
|
556.3
|
3,813
|
4,637
|
-190.7
|
67.73
|
245.8
|
398.6
|
Net income
1 |
456.2
|
434.8
|
2,885
|
3,235
|
-218
|
49.49
|
188
|
322.6
|
Net margin
|
16.13%
|
14.87%
|
43.09%
|
41.01%
|
-9.06%
|
2.51%
|
7.45%
|
10.82%
|
EPS
2 |
0.1353
|
0.1284
|
0.8443
|
0.9464
|
-0.0638
|
0.0179
|
0.0589
|
0.0977
|
Free Cash Flow
1 |
602.1
|
407.7
|
2,727
|
2,874
|
-345.1
|
162.6
|
218.7
|
292.5
|
FCF margin
|
21.29%
|
13.94%
|
40.72%
|
36.44%
|
-14.33%
|
8.25%
|
8.67%
|
9.81%
|
FCF Conversion (EBITDA)
|
89.11%
|
56.59%
|
69.18%
|
60.86%
|
-
|
92.23%
|
58.07%
|
53.51%
|
FCF Conversion (Net income)
|
131.98%
|
93.77%
|
94.51%
|
88.86%
|
-
|
328.57%
|
116.35%
|
90.66%
|
Dividend per Share
2 |
0.0860
|
0.0740
|
0.1770
|
0.5700
|
-
|
0.007110
|
0.0311
|
0.0518
|
Announcement Date
|
5/7/19
|
5/18/20
|
5/4/21
|
5/10/22
|
5/9/23
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2023 Q1
|
2023 Q4
|
---|
Net sales
1 |
-
|
515.7
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
88.28
|
-
|
Net margin
|
-
|
-
|
EPS
2 |
0.0258
|
-0.0886
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
8/9/22
|
5/9/23
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
194
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
31
|
2,326
|
2,139
|
1,575
|
1,641
|
1,659
|
1,702
|
Leverage (Debt/EBITDA)
|
0.2867
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
602
|
408
|
2,727
|
2,874
|
-345
|
163
|
219
|
293
|
ROE (net income / shareholders' equity)
|
21.5%
|
18.1%
|
63%
|
64.1%
|
-3.74%
|
0.94%
|
4.32%
|
7.08%
|
ROA (Net income/ Total Assets)
|
16.2%
|
13.8%
|
45.1%
|
49%
|
-4.46%
|
0.87%
|
3.48%
|
5.36%
|
Assets
1 |
2,812
|
3,155
|
6,399
|
6,607
|
4,889
|
5,710
|
5,398
|
6,014
|
Book Value Per Share
2 |
0.6800
|
0.7600
|
1.450
|
1.500
|
1.360
|
1.380
|
1.400
|
1.430
|
Cash Flow per Share
2 |
0.1900
|
0.1900
|
0.9000
|
1.090
|
-0.0100
|
0.0900
|
0.0900
|
0.1400
|
Capex
1 |
431
|
251
|
361
|
847
|
307
|
161
|
183
|
234
|
Capex / Sales
|
15.24%
|
8.59%
|
5.39%
|
10.73%
|
12.75%
|
8.18%
|
7.26%
|
7.86%
|
Announcement Date
|
5/7/19
|
5/18/20
|
5/4/21
|
5/10/22
|
5/9/23
|
-
|
-
|
-
|
Last Close Price
2.67
MYR Average target price
2.534
MYR Spread / Average Target -5.09% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.11% | 1.91B | | +11.84% | 27.79B | | -32.98% | 2.98B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -13.37% | 1.83B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +4.01% | 1.13B | | +13.51% | 1.12B |
Medical Supplies
|